Advertisement: Cambridge Network
RealVNC mid-banner general
Advertisement Cambridge China Centre
Advertisement: RSM
Advertisement EY mid banner
Barr Ellison Solicitors – commercial property
Mid banner advertisement: BDO
Advertisement: Mogrify
Advertisement: Bradfield Centre mid
RealVNC mid banner careers
ARM Innovation Hub

BioMedTech

  • Further funding for Babraham BioConcepts

    Early-stage life sciences investment company, Babraham BioConcepts, has announced a close of additional funding from the Rainbow Seed Fund, which now... Read More

  • Acambis hits mark

    Acambis announces that it met the deadline for the delivery of smallpox vaccines to the US government, a key target in meeting its 2006 revenue... Read More

  • UK-US alliance

    Zyentia Ltd, a Cambridge based provider of solutions to protein misfolding and aggregation, reports that it has entered into a research collaboration... Read More

  • Tristel granted patents

    Cambridgshire hospital sterilisation specialist, Tristel plc, reported that it had been granted patents from the UK Patent Office for the Tristel... Read More

  • BioProgress in US alliance

    Cambridge specialist drug delivery firm, BioProgress has entered into a collaboration with US-owned Inyx to commercialise its TABWRAP technology.... Read More

  • Biomedical research archive is developed

    The European Bioinformatics Institute (EMBL-EBI) in Hinxton, Cambridge, has provided a new online resource, which provides free access to a permanent... Read More

  • Solexa speeds up

    Genomics instruments developer, Solexa, reports that its genome analysis system has achieved the 1G performance milestone, making it around 100 times... Read More

  • Lectus has its ion future success

    Lectus Therapeutics Ltd, a four-year-old Cambridge drug discovery and development company focusing on next-generation ion channel modulators, has... Read More

  • Richard Dixey leaves Phytopharm

    Richard Dixey, co-founder of plant-based pharmaceutical, Phytopharm, and the company’s chief executive for the last 10 years has left the firm as it... Read More

  • Allergy disorders target

    Cambridge Antibody Technology (CAT) has granted iCo Therapeutics an exclusive worldwide licence for the development and commercialisation of CAT-213... Read More

  • Care UK JV wins contract

    Colchester-based health care provider Care UK has announced that its joint venture company Partner Health Group (PHG) has been appointed preferred... Read More

  • RSA opens in Singapore

    Herts Life Sciences recruitment company RSA has opened a new office in Singapore, with assistance from UK Trade... Read More

  • Inion says it will meet expectations on revenues

    Biodegradable medical implant developer, Inion has announced that it anticipates revenues for 2006 will be around €5.7m, in line with current market... Read More

  • Solexa breaks the one billion barrier

    Genomics instruments developer, Solexa reports that its genome analysis system has achieved the 1G performance milestone, making it around 100 times... Read More

  • Acambis hits December deadline to meet revenue guidance

    Acambis announced that it met the deadline for the delivery of smallpox vaccines to the US government, a key target in meeting its 2006 revenue... Read More

  • Bio company Licht into shape following investment

    Shares in Sareum rose by almost a half from a sub one penny base following news that a founding director of Mercury Asset Management had taken a ten... Read More

  • Babraham heads new European proteomics project

    The Babraham Institute is the co-ordinating partner for a new €1.8m European research infrastructure, ‘ProteomeBinders’, which aims to understand how... Read More

  • Abcam signs distribution deal with Tepnel

    Cambridge-based antibody specialist Abcam has signed a licensing agreement with Tepnel to distribute its Diaclone immunological product range. The... Read More

  • Getinge announces purchase of 15m Huntleigh shares at 480p each

    Further to Business Weekly’s report last week on the acquisition of Luton-based Huntleigh Technologies by Getinge, the Swedish firm has announced... Read More

  • Abcam to be sole distributor for Fusion

    Cambridge online antibody supplier, Abcam, is to be the sole distributor of a product line of 46 immunology research antibodies from Northern Ireland... Read More

Pages